Physician profile
Mayank Patel
NPI 1235558594
$375.72
in general payments reported to CMS, 2019-2025
9 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $121 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $82.03 | 2024-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $58.13 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $42.43 | 2024-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $41.88 | 2024 | Trelegy Ellipta, Arexvy |
| Sanofi Pasteur INC. | $41.37 | 2025 | |
| Telix Pharmaceuticals | $35.08 | 2025 | Illuccix |
| Lilly USA, LLC | $30.76 | 2025 | Mounjaro |
| Blue Earth Diagnostics | $22.49 | 2025 | Posluma |
| Merck Sharp & Dohme LLC | $21.55 | 2025 | Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.